文献速递心力衰竭与心肌病冠心病

CD206+IL-4Rα+巨噬细胞驱动缺血性心肌病不良心脏重构

CD206+IL-4Rα+ Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
PubMed 文献 · Circulation · 2025-05-01

该研究在小鼠非再灌注心肌梗死诱导的心衰模型及人类衰竭心脏中,发现CD206+巨噬细胞持续扩增,心梗后8周约占全部巨噬细胞的85%,其中近半数表达IL-4Rα。通过髓系特异性IL-4Rα敲除和反义寡核苷酸沉默,可耗竭CD206+IL-4Rα+巨噬细胞,减轻纤维化、改善新生血管形成并逆转左室重构,提示抑制该信号轴是缺血性心肌病的潜在治疗策略。

要点

  • 心梗后CD206+巨噬细胞持续扩增,8周时约占心脏巨噬细胞的85%,与左室功能不全和纤维化相关。
  • CD206+IL-4Rα+巨噬细胞通过分泌FIZZ1促进肌成纤维细胞分化,驱动纤维化和不良重构。
  • 髓系IL-4Rα敲除或体内沉默可耗竭CD206+IL-4Rα+巨噬细胞,减轻纤维化并逆转左室重构。

核心结论

  • 心脏CD206+IL-4Rα+巨噬细胞在心衰中增殖扩增,是病理重构和纤维化的关键介质,部分通过分泌FIZZ1实现。
  • 抑制CD206+巨噬细胞的IL-4Rα信号可减轻缺血性心肌病的左室重构。

研究设计与样本

  • 研究采用成年C57BL/6小鼠行非再灌注心肌梗死诱导心衰,使用流式细胞术和免疫染色分析小鼠及人类心脏巨噬细胞。
  • 通过髓系特异性IL-4Rα缺失(IL-4Rαf/fLysM-CreERT2小鼠)和心肌内巨噬细胞过继转移定义IL-4极化巨噬细胞(M[IL-4])的功能效应。
  • 使用反义寡核苷酸在小鼠体内沉默IL-4Rα基因。

主要发现

  • 心梗后CD206+巨噬细胞稳步扩增,8周时约占全部巨噬细胞的85%,呈增殖性、主要为CCR2-和MHC IIhi,与左室功能障碍和纤维化相关。
  • 近半数CD206+巨噬细胞表达IL-4Rα,多数CD206+IL-4Rα+巨噬细胞共表达促纤维化FIZZ1。
  • 骨髓来源的CD206+ M[IL-4]巨噬细胞显著上调FIZZ1,并诱导心脏间充质干细胞和心脏成纤维细胞发生FIZZ1依赖的肌成纤维细胞分化,部分与心脏间充质干细胞中DLL4/Jagged1-Notch1信号相关。
  • 向 naïve 小鼠心肌内过继转移M[IL-4](而非M[IL-10])CD206+巨噬细胞,可在4周内诱导进行性左室重构,增加纤维化、心肌细胞肥大和凋亡。
  • 心梗后4周起始的髓系特异性IL-4Rα基因缺失显著减少CD206+巨噬细胞增殖并有效耗竭CD206+IL-4Rα+心脏巨噬细胞,与左室重构进展受阻、心脏纤维化减少和新生血管形成改善相关。

临床怎么用

  • 靶向CD206+巨噬细胞的IL-4Rα信号可能成为减轻缺血性心肌病左室重构和纤维化的治疗策略。
  • IL-4Rα信号沉默在已建立心衰的小鼠中仍可逆转左室重构,提示其用于心衰治疗的转化潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of cardiac CD (cluster of differentiation) 206+ macrophages in chronic heart failure (HF) is unknown. We examined whether CD206+ macrophages expressing IL (interleukin)-4Rα are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS: Adult C57BL/6 mice underwent nonreperfused myocardial infarction to induce HF. Macrophages in murine and human hearts were profiled using flow cytometry and immunostaining. In vivo myeloid-specific IL-4Rα deletion and intramyocardial macrophage adoptive transfer defined the functional effects of macrophages polarized by IL-4 (M[IL-4]). Antisense oligonucleotides were used for in vivo IL-4Rα gene silencing in mice. RESULTS: CD206+ macrophages steadily expanded in hearts after myocardial infarction, such that at 8 weeks after myocardial infarction, they comprised ≈85% of all macrophages. These macrophages were proliferative, predominantly CCR2- (C-C motif chemokine receptor) and MHC (major histocompatibility complex) IIhi, and correlated with LV dysfunction and fibrosis. Nearly half of CD206+ macrophages expressed IL-4Rα, and the majority of CD206+IL-4Rα+ macrophages coexpressed profibrotic FIZZ (found in inflammatory zone) 1. Bone marrow-derived CD206+ M[IL-4] macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of both cardiac mesenchymal stem cells and cardiac fibroblasts, in part related to DLL (Delta-like ligand)-4/Jagged1-Notch1 signaling in cardiac mesenchymal stem cells. Intramyocardial adoptive transfer of M[IL-4], but not IL-10-polarized (M[IL-10]), CD206+ macrophages to naïve mice induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Rα gene deletion in HF (initiated 4 weeks after myocardial infarction) in IL-4Rαf/fLysM-CreERT2 mice significantly reduced CD206+ macrophage proliferation and effectively depleted CD206+IL-4Rα+ cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Rα gene silencing in mice with established HF effectively depleted cardiac CD206+IL-4Rα+ macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Last, alternatively activated CD206+ and CD163+ macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163+ macrophages expressed IL-4Rα and FIZZ3, the human homolog of FIZZ1. CONCLUSIONS: Cardiac CD206+IL-4Rα+ macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206+ macrophage IL-4Rα signaling alleviates LV remodeling in ischemic cardiomyopathy.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Wang Q, Ismahil MA, Zhu Y, et al. CD206+IL-4Rα+ Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. Circulation. 2025. PMID: 40308203. doi:10.1161/CIRCULATIONAHA.124.072411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。